Innovent Biologics (HK:1801)
:1801
Earnings Data
Report Date
Aug 26, 2026TBA (Confirmed)
Period Ending
2026 (Q2)Consensus EPS Forecast
0.63Last Year’s EPS
0.58Same Quarter Last Year
Strong Buy
Based on 14 Analysts Ratings
HK:1801 Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
HK:1801 Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Mar 26, 2026 | HK$82.55 | HK$79.40 | -3.82% |
Aug 27, 2025 | HK$95.75 | HK$91.00 | -4.96% |
Mar 26, 2025 | HK$39.15 | HK$39.05 | -0.26% |
Aug 28, 2024 | HK$44.30 | HK$44.10 | -0.45% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Innovent Biologics (HK:1801) report earnings?
Innovent Biologics (HK:1801) is schdueled to report earning on Aug 26, 2026, TBA (Confirmed).
What is Innovent Biologics (HK:1801) earnings time?
Innovent Biologics (HK:1801) earnings time is at Aug 26, 2026, TBA (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is the P/E ratio of Innovent Biologics stock?
The P/E ratio of Innovent Biologics is N/A.
What is HK:1801 EPS forecast?
HK:1801 EPS forecast for the fiscal quarter 2026 (Q2) is 0.63.